Literature DB >> 30172580

Quantifying drivers of antibiotic resistance in humans: a systematic review.

Anuja Chatterjee1, Maryam Modarai2, Nichola R Naylor2, Sara E Boyd3, Rifat Atun4, James Barlow5, Alison H Holmes6, Alan Johnson7, Julie V Robotham8.   

Abstract

Mitigating the risks of antibiotic resistance requires a horizon scan linking the quality with the quantity of data reported on drivers of antibiotic resistance in humans, arising from the human, animal, and environmental reservoirs. We did a systematic review using a One Health approach to survey the key drivers of antibiotic resistance in humans. Two sets of reviewers selected 565 studies from a total of 2819 titles and abstracts identified in Embase, MEDLINE, and Scopus (2005-18), and the European Centre for Disease Prevention and Control, the US Centers for Disease Control and Prevention, and WHO (One Health data). Study quality was assessed in accordance with Cochrane recommendations. Previous antibiotic exposure, underlying disease, and invasive procedures were the risk factors with most supporting evidence identified from the 88 risk factors retrieved. The odds ratios of antibiotic resistance were primarily reported to be between 2 and 4 for these risk factors when compared with their respective controls or baseline risk groups. Food-related transmission from the animal reservoir and water-related transmission from the environmental reservoir were frequently quantified. Uniformly quantifying relationships between risk factors will help researchers to better understand the process by which antibiotic resistance arises in human infections.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30172580     DOI: 10.1016/S1473-3099(18)30296-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  59 in total

1.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

2.  Differential Immunomodulatory Activities of Schiff Base Complexes Depending on their Metal Conjugation.

Authors:  Furkan Ayaz; İlyas Gonul; Burcu Demirbag; Kasim Ocakoglu
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.

Authors:  Laura Temime; Lulla Opatowski; David Rm Smith
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

Review 4.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

5.  Vancomycin Heteroresistance and Clinical Outcomes in Bloodstream Infections Caused by Coagulase-Negative Staphylococci.

Authors:  Jason W Rosch; Joshua Wolf; Tina H Dao; Ramzi Alsallaq; Joshua B Parsons; Jose Ferrolino; Randall T Hayden; Jeffrey E Rubnitz; Iftekhar M Rafiqullah; D Ashley Robinson; Elisa B Margolis
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 6.  Defining and combating antibiotic resistance from One Health and Global Health perspectives.

Authors:  Sara Hernando-Amado; Teresa M Coque; Fernando Baquero; José L Martínez
Journal:  Nat Microbiol       Date:  2019-08-22       Impact factor: 17.745

7.  Prevalence of Antibiotic-Resistant Bacteria ESKAPE among Healthy People Estimated by Monitoring of Municipal Wastewater.

Authors:  Masateru Nishiyama; Susan Praise; Keiichi Tsurumaki; Hiroaki Baba; Hajime Kanamori; Toru Watanabe
Journal:  Antibiotics (Basel)       Date:  2021-04-26

8.  The effect of generic market entry on antibiotic prescriptions in the United States.

Authors:  Cecilia Kållberg; Jemma Hudson; Hege Salvesen Blix; Christine Årdal; Eili Klein; Morten Lindbæk; Kevin Outterson; John-Arne Røttingen; Ramanan Laxminarayan
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

Review 9.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 10.  Nanomaterial Shape Influence on Cell Behavior.

Authors:  Daniil V Kladko; Aleksandra S Falchevskaya; Nikita S Serov; Artur Y Prilepskii
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.